Trial Profile
Efficacy of Losartan in Preventing Progression of COPD [chronic obstructive pulmonary disease]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 14 Mar 2017 Status changed from active, no longer recruiting to completed.
- 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jan 2013 Planned end date changed from 1 Aug 2012 to 1 Aug 2013 as reoported by ClinicalTrials.gov.